Tuesday, October 7, 2025
Home Blog Page 1843

Africa has just six years to realise the water, sanitation and hygiene SDG

0

The race is on to realise the most fundamental of the Sustainable Development Goals (SDGs) – ensuring that everyone has access to water, sanitation and hygiene services – by the 2030 deadline, says ForAfrika disaster response director Charles Wentzel.

There are six years to go, and ForAfrika, the largest African humanitarian development organisation, is doing its best to bring water, sanitation and hygiene (WASH) services to as many people as it can in the countries in which it works: Angola, the Central African Republic, Ethiopia, Mozambique, Rwanda, South Africa, South Sudan and Uganda. The SDGs are a set of 17 global objectives established by the United Nations to address social, economic and environmental challenges and promote sustainable development worldwide by 2030.

“Everywhere we work, we collaborate with other development organisations so that resources are effectively allocated, and there is no doubling up. Most important of all, however, is that we work with communities to ensure that the services we help them to provide tie in with their goals and aspirations,” Wentzel says ahead of World Water Day on 22 March.

Bill & Melinda Gates Medical Research Institute Initiates Phase 3 Clinical Trial of Tuberculosis Vaccine Candidate

0

The Bill & Melinda Gates Medical Research Institute (Gates MRI) today announced that a Phase 3 clinical trial to assess the efficacy of the M72/AS01E tuberculosis (TB) vaccine candidate is now underway, with first doses given in South Africa, where TB takes a heavy toll. If shown to be well-tolerated and effective, M72/AS01E could potentially become the first vaccine to help prevent pulmonary TB in adolescents and adults, the most common form of the disease, and the first new TB vaccine in over a century.  

Globally, according to the World Health Organization, an estimated 10.6 million people fell ill with TB in 2022 and 1.3 million died — over 3,500 people per day. The disease primarily affects people in low- and middle-income countries, and those at highest risk are often living in poverty, with poor living and working conditions and undernutrition. In South Africa alone, around 280,000 people are diagnosed with TB each year. 

“The launch of this pivotal Phase 3 trial demonstrates our commitment to harnessing the power of medical innovation to fight diseases like TB that are particularly devastating for low- and middle-income countries,” said Emilio A. Emini, Ph.D., CEO of the Gates MRI. “Clinical study of the vaccine will still require years, but our incredible partners in South Africa and elsewhere who have come together for the Phase 3 study share our hope in the vaccine’s potential.”

U.S. Embassy supports local conflict resolution workshops in Mekelle and Addis Ababa 

0

Conflict over land, water, and other natural resources are at the root of many historical and modern conflicts in Ethiopia and around the world.  The UN anticipates that climate change will acerbate resource-based conflict in the coming years. 

Recognizing that constructive dialogue is the only durable solution to peace in Ethiopia, the U.S. Embassy in Ethiopia supported one-day workshops in Mekelle and Addis Ababa March 13 and 15 to introduce conflict mediation mechanisms with demonstrated success in defusing community-level resource-based conflict.  The workshops trained sixty-five government officials, university faculty, civil society leaders and think tanks working on environment on how to integrate mediation techniques into their strategies for resolving local land and resource disputes by encouraging all parties to look for shared interests that lead to pathways out of conflict and towards constructive problem solving.  

This Restorative Practices for Environmental Problems project was implemented by Mekelle and Bahir Dar Universities through a U.S. government grant.

COP28 goal of tripling renewables feasible only with urgent global course correction

0

Achieving the global target set at COP28 to triple renewable power capacity by 2030 relies heavily on establishing conducive conditions for such growth. Tripling renewable power capacity by 2030 is technically feasible and economically viable, but its delivery requires determination, policy support and investment at-scale.

“Tracking COP28 outcomes: Tripling renewable power capacity by 2030” highlights that 2023 has set a new record in renewable deployment, adding 473 gigawatts (GW) to the global energy mix. However, the brief by the International Renewable Energy Agency (IRENA) concludes that tripling renewable power capacity depends on overcoming systemic and structural barriers to the energy transition.

Evolving policies, geopolitical shifts and declining costs have all played a role in propelling the rapid expansion of renewable energy in markets worldwide. Yet, to triple renewable power capacity, concerted efforts are required to enhance infrastructure, policies and workforce capabilities, underpinned by increased financing and closer international cooperation, as outlined in IRENA’s World Energy Transitions Outlook brief presented at the Berlin Energy Transitions Dialogue.